NCT01112787View on ClinicalTrials.gov

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

March 26, 2010

Primary Completion Date

April 26, 2010

Study Completion Date

April 26, 2010

Conditions

Acne Vulgaris

Interventions

DRUG

Tazarotene Foam

Tazarotene Foam

DRUG

Vehicle Foam

Vehicle Foam

DRUG

Sodium Laural Sulfate

Sodium Laural Sulfate

DRUG

Distilled Water

Distilled Water

Trial Locations (1)

85251

HillTop Research Corporation, Scottsdale

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY

NCT01112787 - A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers | Biotech Hunter | Biotech Hunter